Navigation Links
OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland
Date:3/8/2013

FORT LAUDERDALE, Fla., March 8, 2013 /PRNewswire/ -- OrbusNeich Medical Inc. and its subsidiary, Orbus International B.V., (collectively, "OrbusNeich") today announced that they have commenced a patent infringement lawsuit in Ireland against Boston Scientific Corporation (NYSE: BSX) and two of its Irish subsidiaries (collectively, "Boston Scientific").

The lawsuit alleges that Boston Scientific are infringing two European patents covering certain novel stent designs.  The two patents, held by OrbusNeich, are designated EP 2 311 412 and EP 1 341 482.  OrbusNeich allege that the patents are infringed by a number of Boston Scientific's coronary stent systems, including the "PROMUS Element™", "PROMUS Element Plus™", "OMEGA™", "TAXUS™", "SYNERGY™", and "Promus PREMIER™" lines of stents.

OrbusNeich are seeking damages for the infringement and an injunction prohibiting Boston Scientific from manufacturing, offering for sale, marketing or stocking products that infringe the patents in Ireland.

Al Novak , Chairman and Chief Executive Officer of OrbusNeich, said, "The lawsuit in Ireland is a continuation of our efforts to protect and enforce our intellectual property rights. We intend to vigorously pursue these efforts to prevent unlawful competitive practices and protect our unique technologies throughout the world."

On February 20, 2013, OrbusNeich commenced patent infringement actions in Germany and the Netherlands against Boston Scientific and its distribution affiliates in those countries.  

On February 11, 2013, OrbusNeich received a favorable ruling from the European Patent Office (EPO) in connection with EP 1 34
'/>"/>

SOURCE OrbusNeich
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Early Coronary Artery Healing Advantage of OrbusNeichs Combo Dual Therapy Stent™ Compared to the TAXUS® Stent Shown in Two Clinical Trial Subgroup Analyses
2. OrbusNeich Announces Favorable Ruling From the European Patent Office
3. OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
4. Essential Medical Dismisses Patent Case against Masimo and Cercacor
5. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
6. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
7. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
8. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
9. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
10. Broad Patent Protection Granted for iBio Immunomodulator
11. Bio-AMD, Inc.; Patent Application for Cartridge Test Cap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ST. LOUIS, July 28, 2015  Express Scripts Holding ... net income attributable to Express Scripts stockholders of $600.1 ... diluted share, as detailed in Table 4, were $1.44 ... "It is clear many companies across healthcare are validating ... Chairman and Chief Executive Officer. "But, what matters most ...
(Date:7/28/2015)... 28, 2015 /PRNewswire-USNewswire/ -- Kentucky,s ... doctor shopping after a 2012 law required providers to ... medications is yet more evidence that Californians need the ... Since Kentucky,s prescription drug abuse ... declined by 52 percent; opioid prescriptions to doctor-shopping individuals ...
(Date:7/28/2015)... July 28, 2015 A German Diabetes Center ... L. reuteri probiotic enriches human gut microbiota and ... secretion.  The study involved daily administration of Nutraceutix,s ... using the patented BIO- tract ® delivery ... acid on their way to the intestinal tract. ...
Breaking Medicine Technology:Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2
... 2011 The U.S.-Russia Business Council is pleased to announce ... to establish two new joint ventures in Russia. These joint ... markets while enhancing Russia,s power generation and healthcare sectors. ... than US$10 – 15 billion in sales, GE will sell ...
... signing of the America Invents Act represents a huge ... aligning new patent laws more closely with those from ... Chief Executive Officer of Eli Lilly and Company (NYSE: ... President Obama,s signing ceremony today in Alexandria, Va.  The ...
Cached Medicine Technology:USRBC President Ed Verona Lauds GE Announcement on Energy and Healthcare Joint Ventures in Russia 2A Win for Innovation: President Signs America Invents Act 2
(Date:7/29/2015)... ... July 29, 2015 , ... TransFlip is an all ... drag & drop presets for FCPX, these transitions are easy to apply and modify ... to each transition. With over 60 preset styles, kinetic flipping panel animations are just ...
(Date:7/29/2015)... Arizona (PRWEB) , ... July 29, 2015 , ... ... dorms. The project, which will by the end will cost the 501(c) organization nearly ... of Arizona’s recent anti-ligature requirements. , “We took it down to the studs,” ...
(Date:7/29/2015)... ... July 29, 2015 , ... HealthPostures ( https://healthpostures.com ), ... with 247Ergo, an ergonomics specialty firm. Purpose of the partnership is to help ... undertake could improve worker mobility, functionality and fitness levels. , Executives at ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth ... in Sarasota to be chosen by the manufacturer to offer and perform ... injectable, non-invasive way to treat and eliminate double chin fat,” Dr. Callahan explained. ...
(Date:7/29/2015)... ... July 29, 2015 , ... ITW Dynatec, along with Zip-Pak ... Powers is responsible for driving growth and innovation across ITW Dynatec’s worldwide customer ... as an effective leader within the ITW community speaks for itself. We are ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3
... scientists, led by Tracy Hussell at Imperial College, London, ... vulnerable to infection with pneumonia-causing bacteria. Components of these ... lung. These signals result in the recruitment of other ... bugs. But in post-flu mice, these receptors were not ...
... , Fighting fat bloom can mean a prettier ... Food Chemistry , Chemists in England and the Netherlands ... Valentines Day chocolates, and other goodies, looking fresher and tastier. ... the outside of chocolate, is scheduled for the March 12 ...
... Viral Load Testing to the U.S. ... ... Siemens Healthcare, (http://www.siemens.com/diagnostics ) announced today that its VERSANT(TM) 440,Molecular ... Drug,Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay ...
... stem works, linguist says , , MONDAY, Feb. 18 (HealthDay ... the development of the brain more than previously thought, ... stem, but it,s tuned differently depending on what sounds ... sounds of his or her mother tongue," Jackson T. ...
... on cocaine addiction - and attempts to block its ... reabsorb the brain,s "reward" chemical once its signal is ... recycling job, it leaves the feel-good chemical around to ... conducted at the U.S. Department of Energy,s Brookhaven National ...
... International Limited (NYSE: MR ), a leading developer, ... that it will,report its financial results for the fourth ... U.S. market closes on March 5, 2008. Mindray,s,management will ... March 5,2008 U.S. Eastern Time (9:00 AM on March ...
Cached Medicine News:Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 2Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 3Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 4Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 5Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 6Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 7Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 8Health News:American Chemical Society's Weekly PressPac -- Feb. 13, 2008 9Health News:Siemens Receives FDA Approval for the VERSANT 440 Molecular System 2Health News:Siemens Receives FDA Approval for the VERSANT 440 Molecular System 3Health News:Pitch Patterns Play Greater Role in Speech Perception 2Health News:Cocaine's effects on brain metabolism may contribute to abuse 2Health News:Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5, 2008 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: